Convection enhanced delivery/AAV2-GDNF

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01621581 (ClinicalTrials.gov)	March 13, 2013	14/6/2012	AAV2-GDNF for Advanced Parkinson s Disease	A Phase 1 Open-Label Dose Escalation Safety Study of Convection EnhancedDelivery (CED) of Adeno-Asso ...	Parkinson's Disease	Genetic: Convection enhanced delivery/AAV2-GDNF	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	18 Years	N/A	All	25	Phase 1	United States

First Previous1Next Last